New juvenile rheumatoid arthritis research from Selcuk University discussed
2007 OCT 29 -- "'Juvenile rheumatoid arthritis (JRA) is a complex disease involving the interactions of several cell populations with different mediators. Herein, we report a five-year-old girl with systemic-onset JRA," researchers in Konya, Turkey report. "At admission, peripheral blood flowcytometric analysis showed the percentages of CD19(+)and CD20(+) stop B cells were < 1%. These values returned to normal on the tenth day of steroid treatment. This is the first report of JRA presented with absence of B lymphocytes in the literature and suggested that lymphocytes subset analysis could change with treatment in patients with JRA," wrote H. Artac and colleagues, Selcuk University. The researchers concluded: "Different clinical signs and symptoms reflecting aspects of JRA are critical for the etiology of the disease and to identify new strategies for treatment." Artac and colleagues published their study in Rheumatology International (Systemic onset juvenile rheumatoid arthritis presenting with absence of B lymphocytes. Rheumatology International, 2007;27(10):981-983). For additional information, contact H. Artac, Selcuk University Meram Med Faculty, Dept. of Pediatrics, Beysehir Yolu, TR-42080 Konya, Turkey. Publisher contact information for the journal Rheumatology International is: Springer, 233 Spring Street, New York, NY 10013, USA. Keywords: Turkey, Konya, Autoimmune Disease, Immunology, Juvenile Rheumatoid Arthritis, Rheumatology, Selcuk University. This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2007, Pain & Central Nervous System Week via NewsRx.com.
|
